164 related articles for article (PubMed ID: 2540654)
21. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
[TBL] [Abstract][Full Text] [Related]
22. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
23. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
Murad TM; Longley JV; Lurain JR; Brewer JI
Int J Gynaecol Obstet; 1990 Aug; 32(4):359-67. PubMed ID: 1977631
[TBL] [Abstract][Full Text] [Related]
24. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
25. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy.
Khazaeli MB; Hedayat MM; Hatch KD; To AC; Soong SJ; Shingleton HM; Boots LR; LoBuglio AF
Am J Obstet Gynecol; 1986 Aug; 155(2):320-4. PubMed ID: 3017111
[TBL] [Abstract][Full Text] [Related]
27. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole.
Kim DS; Moon H; Kim KT; Moon YJ; Hwang YY
Obstet Gynecol; 1986 May; 67(5):690-4. PubMed ID: 3008055
[TBL] [Abstract][Full Text] [Related]
28. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
Ho Yuen B; Burch P
Am J Obstet Gynecol; 1983 Jan; 145(2):214-7. PubMed ID: 6849356
[TBL] [Abstract][Full Text] [Related]
29. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
30. Treatment of gestational trophoblastic disease.
Seckl MJ; Newlands ES
Gen Diagn Pathol; 1997 Nov; 143(2-3):159-71. PubMed ID: 9443572
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
32. [Hormonal contraception after evacuation of hydatid mole (author's transl)].
Donát J; Chalupa M
Cesk Gynekol; 1981 May; 46(4):286-9. PubMed ID: 7249096
[No Abstract] [Full Text] [Related]
33. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole.
Matsui H; Iitsuka Y; Suzuka K; Seki K; Sekiya S
Hum Reprod; 2001 Jun; 16(6):1274-7. PubMed ID: 11387305
[TBL] [Abstract][Full Text] [Related]
34. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases.
Zalel Y; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):67-71. PubMed ID: 9031962
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive use and risk of gestational trophoblastic tumors.
Palmer JR; Driscoll SG; Rosenberg L; Berkowitz RS; Lurain JR; Soper J; Twiggs LB; Gershenson DM; Kohorn EI; Berman M; Shapiro S; Rao RS
J Natl Cancer Inst; 1999 Apr; 91(7):635-40. PubMed ID: 10203284
[TBL] [Abstract][Full Text] [Related]
36. Effects of prophylactic chemotherapy for postmolar trophoblastic disease in patients with complete hydatidiform mole.
Ayhan A; Ergeneli MH; Yüce K; Yapar EG; Kisnisci AH
Int J Gynaecol Obstet; 1990 May; 32(1):39-41. PubMed ID: 1971236
[TBL] [Abstract][Full Text] [Related]
37. Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease.
Iwase K; Okamoto T; Nui R; Mizutani S
Gynecol Obstet Invest; 2001; 51(4):228-32. PubMed ID: 11408732
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
40. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
